A group of scientists in China has revealed a novel mechanism whereby a short form of IL-18, generated by caspase-3 cleavage in tumor cells, activates natural killer (NK) cells to suppress tumor growth, offering new therapeutic opportunities. The research is published in the journal Nature Immunology.
This article was originally published on MedicalXpress.com